SI-BONE Gains Expanded Indication for the iFuse-TORQ Implant

SI-BONE received FDA clearance to market iFuse-TORQ® for pelvic fracture fixation, including acute, non-acute and non-traumatic fractures. Fractures covered in this clearance include pelvic fragility fractures (those related to low-energy traumatic events) and pelvic insufficiency fractures.

Sacral fragility and insufficiency fractures are...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us